BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,969.34
      0.35%
      US Tech 100
      20,266.40
      0.33%
      Dow Jones
      44,296.51
      0.97%
      Brent Oil
      74.745
      -0.03%
      Bitcoin
      98,158.00
      0.29%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. DiaMedica Therapeutics Inc (DMAC)

      7. DiaMedica Therapeutics Inc (DMAC) Financials

      DiaMedica Therapeutics Inc

      DiaMedica Therapeutics Inc (DMAC)

      NASDAQ
      4.70
      0.52
      (12.44%)
      Closed November 25 4:00PM
      Delayed by 15 minutes
      4.73
      0.03
      (0.64%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      DiaMedica Therapeutics Inc Financial Summary

      The current DMAC market cap is 200.97M. The company's latest EPS is USD -0.4532 and P/E is -10.44.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 527k0000
      Operating Income -4.21M-5.16M-5.85M-5.74M-5.64M
      Net Income -4.48M-4.47M-5.16M-5.15M-5.12M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -11.59M-12.7M-13.65M-14M-21.27M
      Net Income -10.65M-12.29M-13.59M-13.68M-19.38M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 62.05M58.14M54.16M49.26M56.79M
      Total Liabilities 2.31M2.51M3.1M2.91M3.38M
      Total Equity 59.74M55.63M51.06M46.35M53.42M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 9.05M28.1M45.55M34.4M54.16M
      Total Liabilities 1.44M2.08M1.53M2.57M3.1M
      Total Equity 7.62M26.01M44.02M31.83M51.06M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.12M-14.92M-18.73M-6.65M-11.17M
      Investing -25.62M-24.42M-18.3M4.21M8.94M
      Financing 36.85M36.84M36.84M-1,00011.75M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.1M-9.19M-12.25M-11.51M-18.73M
      Investing -3.91M-16.13M-20.54M11.54M-18.3M
      Financing 70k28.85M30.09M-6k36.84M

      Stats and Ratios

      Market Cap 200.97M
      Price to Earnings Ratio -10.44
      Price to Sales Ratio 0
      Price to Cash Ratio 44.54
      Price to Book Ratio 3.96
      Dividend Yield -

      Share Statistics

      Shares Outstanding 42.76M
      Average Volume (1 week) 266.08k
      Average Volume (1 Month) 97.8k
      52 Week Change 91.06%
      52 Week High 4.95
      52 Week Low 2.14
      Spread (Intraday) 0.25 (5.25%)

      Company Info

      Company Name DiaMedica Therapeutics Inc
      Address 301 carlson parkway, suite 210
      minneapolis, minnesota 55305
      Website https://www.diamedica.com
      Industry pharmaceutical preparations (2834)